Zynerba Pharmaceuticals to Present at Upcoming Investor Conferences

DEVON, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments, today announced that Armando Anido, Chairman and Chief Executive Officer, will provide a company overview at two investor conferences in November: